Back to Stocks
Stock detail
Regeneron Pharmaceuticals, Inc.
REGNSTOCKS | US | NASDAQ | Healthcare | Biotechnology
Profile snapshotUSD 695.2Market cap USD 71.6B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishOrder Block Setup15M28 Jul 26, 15:4564
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4590
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4590
BullishOrder Block Setup4H28 Jul 26, 13:3081
BullishOrder Block Setup4H28 Jul 26, 13:3081
BearishOrder Block Setup1D28 Jul 26, 00:0064
BullishOliver Kell Momentum Setup1D28 Jul 26, 00:0079
BearishOrder Block Setup1D28 Jul 26, 00:0064
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 8.5B+29.6%USD 16.1B+89.1%USD 12.2B-24.3%USD 13.1B+7.8%USD 14.2B+8.3%USD 14.3B+1.0%
Net incomeUSD 3.5B+66.0%USD 8.1B+129.9%USD 4.3B-46.3%USD 4B-8.9%USD 4.4B+11.6%USD 4.5B+2.1%
Net profit margin41.3%+28.1%50.2%+21.5%35.6%-29.1%30.1%-15.4%31.1%+3.1%31.4%+1.1%
EPS32.65+68.5%76.4+134.0%40.51-47.0%37.05-8.5%40.9+10.4%43.07+5.3%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 3.8B+10.3%USD 3B-3.7%USD 3.7B+3.6%USD 3.8B+0.9%USD 3.9B+2.5%USD 3.6B+19.0%
Net incomeUSD 917.7M-20.9%USD 808.7M+12.0%USD 1.4B-2.8%USD 1.5B+8.9%USD 844.6M-8.0%USD 727.2M-10.1%
Net profit margin24.2%-28.3%26.7%+16.3%37.9%-6.2%38.9%+7.9%21.7%-10.2%20.2%-24.5%
EPS8.53-21.6%7.58+13.1%13.24-0.1%14.09+13.6%8.21-3.8%6.99-7.8%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30